Amid the gridlock that has seized Washington, NCI faces a grim and disturbing FY2024, the institute’s Principal Deputy Director Douglas R. Lowy said at the annual meeting of the Association of American Cancer Institutes.
As Robert A. Winn begins his two-year term as president of the Association of American Cancer Institutes, his presidential initiative of “Inclusive Excellence” aims to increase collaboration among cancer centers, their communities, and other cancer organizations in the United States and abroad.
At a time of intensifying national polarization over critical race theory and affirmative action, leaders of cancer centers are faced with two challenges that appear to be diametrically at odds with each other
Robert A. Winn, director of VCU Massey Comprehensive Cancer Center, became president of the Association of American Cancer Institutes at the conclusion of the 2023 AACI/CCAF annual meeting in Washington, DC, Oct. 3.
The following people received awards at the 2023 annual meeting of the Association of American Cancer Institutes:
The American Association for Cancer Research has established the AACR Cancer Centers Alliance to foster collaboration between cancer centers.
The AACI CTO Staff Retention Task Force published a report that highlights key data from two surveys distributed to cancer center directors in March 2022 and again in March 2023.
Amelie Ramirez, chair of the Department of Population Health Sciences and leader of Salud America! at UT Health San Antonio, won the 2023 Association of American Cancer Institutes Cancer Health Equity Award.
Joann B. Sweasy, director of the University of Arizona Cancer Center, was elected by the members of the Association of American Cancer Institutes to be vice president/president-elect of the AACI Board of Directors.
By the end of World War I, the use of chemical weapons had resulted in over one million casualties on both sides, including many disabled and wounded. Through a series of unintended events, these chemical weapons set in motion discoveries that led to the development of chemotherapy.
